Pink Sheet Podcast: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging

 
• By Derrick Gingery and Sarah Karlin-Smith

Pink Sheet reporter and editor discuss the FDA’s latest advertising enforcement letter, which targeted a migraine treatment TV commercial featuring Serena Williams, and its impact on drug promotion, as well as the now growing list of legal cases targeting agency decisions with Chevron deference overturned.

Pink Sheet podcast
Could sponsors reconsider using celebrity endorsement ads after the FDA's recent enforcement actions? • Source: Citeline/Shutterstock

More from Marketing & Advertising

More from Compliance